产品分类

2-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]-1,5-萘啶
CAS号: 446859-33-2
M.F: C17H13N5
M.W: 287.318
Description:
IC50 Value: N/A
RepSox can efficiently replace transgenic Sox2 in the absence of VPA and cMyc, as well as in both embryonic and adult fibroblasts, we chose to further characterize E-616452 and named it RepSox, for Replacement of Sox2.
in vitro: Pretreated MEFs with RepSox, applying the chemical for three days, and then removed it at the time of transduction with Oct4, Klf4, and cMyc. In these experiments, no Oct4+GFP+ colonies were formed, suggesting that RepSox does not act on the initial somatic cells to replace Sox2. Consistent with this result, we did not detect a significant increase in the expression of endogenous Sox2or closely related Sox family members upon RepSox treatment [1]. RepSox did increase by 5-fold the expression of L-Myc, a close homolog of cMyc that can functionally replace it in reprogramming.


公司地址
中山市火炬开发区联园路 第6号厂区A7栋3楼

公司传真
0760-86925768

公司电话
0760-86925768

公司邮箱
SEAS168@HIHOPHARM.COM
电 话:0760-86925768;18824993998 传 真:0760-86925770 地 址:中山市火炬开发区联园路第6号厂区A7栋3楼
页面版权所有 © 2020 中山海泓药业有限公司 粤ICP备17003791号 网站建设:中企动力中山